GNIPST Bulletin 36.4

8/11/2019 GNIPST Bulletin 36.4

1/19

22-08-2014

Click here to go at the top

G

G

N

N

I

I

P

P

S

S

T

T

U

U

L

L

L

L

T

T

I

I

N

N

2

2

1

1

4

4

22nd

August, 2014 Volume No.: 36 Issue No.: 04

Vision

TO REACH THE PINNACLE OF GLORY AS A CENTRE OF EXCELLENCE IN THE OF PHARMACEUTICAL AND BIOLOGICAL SCIENCES BY KNOWLEDGE BAS

LEARNING AND PRACTICE

ontentsMessage from PRINCIPAL

Editorial board

Historical article

News Update

Knowledge based Article

Disease Related Breaking

News

Upcoming Events

Drugs Update

Campus NewsStudents Section

Editors Note

Archive

GNIPST Photo Gallery

or your comments/contribution

For ack-Issues,

ailto:[email protected]

GURU NANAK INSTITUTE OF PHARMACEUTICAL

SCIENCE AND TECHNOLOGY

Website: http://gnipst.ac.in
https://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7mailto:[email protected]:[email protected]:[email protected]://plus.google.com/u/0/photos/111714720327580099858/albums/5897323676427099873?sort=7


2/19

22-08-2014


MESSAGE FROM PRINCIPAL

"It can happen. It does happen.

But it can't happen if you quit." Lauren Dane.

We are what we repeatedly do.

Excellence then is not an act, but a habit. Aristotle

It gives me immense pleasure to pen a few words for our e-bulletin. At the onset I would like to thank t

last years editors and congratulate the newly selected editors for the current year.

Our first consideration is always in the best interest of the students. Our goal is to promote academexcellence and continuous improvement.

I believe that excellence in education is aided by creating a learning environment in which all learners a

supported in maximizing their potential and talents. Education needs to focus on personalized learni

and instruction, while promoting an education system that is impartial, universally accessible, and meetin

the needs of all students.

It is of paramount importance that our learners have sufficient motivation and encouragement in order

achieve their aims. We are all very proud of you, our students, and your accomplishments and lo

forward to watching as you put your mark on the profession in the years ahead.

The call of the time is to progress, not merely to move ahead. Our progressive Management is looki

forward and wants our Institute to flourish as a Post Graduate Institute of Excellence. Steps are taken

this direction and fruits of these efforts will be received by our students in the near future. Our Teache

are committed and dedicated for the development of the institution by imparting their knowledge and pl

the role of facilitator as well as role model to our students.

The Pharmacy profession is thriving with a multitude of possibilities, opportunities and positi

challenges. At Guru Nanak Institute of Pharmaceutical Science and Technology, our focus is on holis

needs of our students.

I am confident that the students of GNIPST will recognize all the possibilities, take full advantage of th

opportunities and meet the challenges with purpose and determination.

Excellence in Education is not a final destination, it is a continuous walk. I welcome you to join us

this path.

My best wishes to all.

Dr. A. Sengupta

1


3/19

22-08-2014


EDITORIAL BOARD

CHIEF EDITOR DR. ABHIJIT SENGUPTA

EDITOR MS. JEENATARA BEGUM

ASSOCIATE EDITOR MR. DIPANJAN MANDAL

HISTORICAL ARTICLE

Terra Sigillata An Early Trademarked DrugMan learned early of the prestigious advantage of trademarks as a

means of identification of source and of gaining customers'

confidence. One of the first therapeutic agents to bear such a mark

was Terra Sigillata (Sealed Earth), a clay tablet originating on theMediterranean island of Lemnos before 500 B.C. One day each year

clay was dug from a pit on a Lemnian hillside in the presence of

governmental and religious dignitaries. Washed, refined, rolled to

a mass of proper thickness, the clay was formed into pastilles and

impressed with an official seal by priestesses, then sun-dried. The

tablets were then widely distributed commercially.

NEWS UPDATE

Experimental Ebola drugs must be fairly

distributed, tested ethically in clinical trials:

(21stAugust, 2014)Critical ethical principles need to be adhered to if experimental

drugs are to be deployed in the Ebola outbreak, bioethicists say,stating that the patients selected to receive such drugs must not be

limited to well-off or well-connected patients - including health

care professionals. These experts also point out that, given the

limited supply of experimental drugs and their low probability of

2


4/19

22-08-2014


success, containment of the epidemic and strengthening health

systems in affected regions should be a priority.

Models to study polyelectrolytes developed,including DNA, RNA: (21stAugust, 2014)A novel and versatile modeling strategy has been developed to

simulate polyelectrolyte systems. The model has applications for

creating new materials as well as for studying polyelectrolytes,

including DNA and RNA. Polyelectrolytes are chains of molecules

that are positively or negatively charged when placed in water.

Because they are sensitive to changes in their environment,polyelectrolytes hold promise for use in applications such as drug

delivery mechanisms.

Adherence to diet can be measured from blood:

(21stAugust, 2014)New results show that it's possible to assess dietary compliance

from a blood sample. This is especially useful in controlled dietary

intervention studies investigating the health benefits of specific

diets. So far, such studies have mainly relied on the participants'

self-reported dietary intake, which is often biased, making it more

difficult to assess the real health benefits.

Missing Protein Restored in Patients with

Muscular Dystrophy: (20thAugust, 2014)

A research team has succeeded in restoring a missing repairprotein in skeletal muscle of patients with muscular dystrophy, a

scientific first. The team has offered a proof-of-principle study and

restored the missing protein in skeletal muscle of patients with

muscular dystrophy. Three patients carrying a dysferlin mutation

3


5/19

22-08-2014


received a single systemic dose of a proteasome inhibitor. After

only a few days the patients musculature produced the missing

dysferlin protein at levels that could be therapeutically effective.

Exercise may protect older women from irregularheartbeat: (20thAugust, 2014)Increasing the amount or intensity of physical activity can cut the

chances of older women developing a life-threatening irregular

heartbeat, according to new research. Researchers found that post-

menopausal women who were the most physically active had a 10

percent lower risk of developing atrial fibrillation (AF), compared

to women with low levels of physical activity, even if they wereobese. Obesity is an important risk factor for atrial fibrillation.

Severing nerves may shrink stomach cancers:

Botox injections slow growth of stomach tumors

in mice: (20thAugust, 2014)Nerves may play a critical role in stomach cancer growth and that

blocking nerve signals using surgery or Botox(onabotulinumtoxinA) could be an effective treatment for the

disease. Stomach cancer is the fourth-leading type of cancer and

the second-highest contributor to cancer mortality worldwide,

with a 5-year survival rate of less than 25 percent.

Seals and sea lions likely spread tuberculosis to

humans: (20thAugust, 2014)Scientists who study tuberculosis have long debated its origins.

New research shows that tuberculosis likely spread from humans

in Africa to seals and sea lions that brought the disease to South

America and transmitted it to Native people there before

Europeans landed on the continent.

4


6/19

22-08-2014


Scientists learn more about rare skin cancer

that killed Bob Marley: (20thAugust, 2014)Acral melanomas, the rare type of skin cancer that caused musician

Bob Marleys death, are genetically distinct from other types of

skin cancer. Acral melanoma most often affects the palms of the

hands, soles of the feet, nail-beds and other hairless parts of the

skin. Unlike other more common types of melanoma, it's not

caused by UV damage from the sun.

Teen sleeplessness piles on risk for obesity:

(20th

August, 2014)Teenagers who don't get enough sleep may wake up to worseconsequences than nodding off during chemistry class. According

to new research, risk of being obese by age 21 was 20 percent

higher among 16-year-olds who got less than six hours of sleep a

night, compared with their peers who slumbered more than eight

hours.

Severe infections with hospitalization afterprostate biopsy rising in Sweden: (20thAugust,

2014)Transrectal ultrasound guided biopsy is the gold standard for

detecting prostate cancer, but international reports have suggested

that the number of risks associated with the procedure is

increasing. In a new nationwide population-based study, Swedish

researchers found that six percent of men filled a prescription for

antibiotics for a urinary tract infection within 30 days after having

a prostate biopsy, with a twofold increase in hospital admissions

over five years.

5


7/19

22-08-2014


Novel gene predicts both breast cancer relapse,

response to chemotherapy: (20thAugust, 2014)Scientists have made it easier to predict both breast cancer

relapses and responses to chemotherapy, through the

identification of a unique gene. The newly found marker could help

doctors classify each breast cancer patient and customize a

treatment regimen that is more effective.

Gene therapy protects mice from lethal heart

condition, researchers find: (20thAugust, 2014)

A new gene therapy has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy. About

one in 3,500 children, mostly boys, are born with Duchenne

muscular dystrophy (DMD). They experience a progressive

wasting away of muscles, starting in the legs and pelvis. Children

with DMD have difficulty walking, and most need wheelchairs by

age 12.

Coronary arteries hold heart-regenerating cells:(20thAugust, 2014)Endothelial cells residing in the coronary arteries can function as

cardiac stem cells to produce new heart muscle tissue,

investigators have discovered. The heart has long been considered

to be an organ without regenerative potential, said one expert.

Recent findings, however, have demonstrated that new heart

muscle cells are generated at a low rate, suggesting the presence ofcardiac stem cells. The source of these cells was unknown.

For detail mail toeditor

6
mailto:[email protected]:[email protected]:[email protected]


8/19

22-08-2014


KNOWLEDGE BASED ARTICLE

Amyotrophic Lateral Sclerosis (ALS)A-myo-trophic comes from the Greek language. "A" means no or

negative. "Myo" refers to muscle, and "Trophic" meansnourishment"No muscle nourishment." When a muscle has no

nourishment, it "atrophies" or wastes away. "Lateral" identifies the

areas in a person's spinal cord where portions of the nerve cells

that signal and control the muscles are located. As this area

degenerates it leads to scarring or hardening ("sclerosis") in the

region.

It is characterised by musclespasticity,rapidly progressiveweakness due tomuscle atrophy,difficulty in speaking

(dysarthria), swallowing (dysphagia), and breathing (dyspnea).

ALS is the most common of the fivemotor neuron diseases.

As motor neurons degenerate, they can no longer send impulses to

the muscle fibers that normally result in muscle movement. Early

symptoms of ALS often include increasing muscle weakness,

especially involving the arms and legs, speech, swallowing orbreathing. When muscles no longer receive the messages from the

motor neurons that they require to function, the muscles begin to

atrophy (become smaller). Limbs begin to look "thinner" as muscle

tissue atrophies.

7
http://en.wikipedia.org/wiki/Spasticityhttp://en.wikipedia.org/wiki/Muscle_atrophyhttp://en.wikipedia.org/wiki/Dysarthriahttp://en.wikipedia.org/wiki/Dysphagiahttp://en.wikipedia.org/wiki/Dyspneahttp://en.wikipedia.org/wiki/Motor_neuron_diseasehttp://en.wikipedia.org/wiki/Motor_neuron_diseasehttp://en.wikipedia.org/wiki/Dyspneahttp://en.wikipedia.org/wiki/Dysphagiahttp://en.wikipedia.org/wiki/Dysarthriahttp://en.wikipedia.org/wiki/Muscle_atrophyhttp://en.wikipedia.org/wiki/Spasticity


9/19

22-08-2014


The body has many kinds of nerves. There are those involved in the

process of thinking, memory, and of detecting sensations (such as

hot/cold, sharp/dull), and others for vision, hearing, and other

bodily functions. The nerves that are affected when you have ALS

are the motor neurons that provide voluntary

movementsand muscle power. Examples of voluntary movements

are your making the effort to reach for the phone or step off a curb;

these actions are controlled by the muscles in the arms and legs.

The heart and the digestive system are also made of muscle but adifferent kind, and their movements are not under voluntary

control. When your heart beats or a meal is digested, it all happens

automatically. Therefore, the heart and digestive system are not

involved in ALS. Breathing also may seem to be involuntary.

Remember, though, while you cannot stop your heart, you can

hold your breath - so be aware that ALS may eventually have an

impact on breathing.

Although the cause of ALS is not completely understood, the

recent years have brought a wealth of new scientific understanding

regarding the physiology of this disease.

8


10/19

22-08-2014


Causes:

Genetics:

There is a known hereditary factor in familial ALS, where the

condition is known to run in families. A defect onchromosome 21,

which codes forsuperoxide dismutase,is associated with

approximately 20% of familial cases of ALS, or about 2% of ALS

cases overall. This mutation is believed to be transmitted in

anautosomal dominantmanner, and has over a hundred different

forms of mutation. The most common ALS-causing mutation is a

mutant SOD1 gene, seen in North American patients; this is

characterized by an exceptionally rapid progression from onset todeath. The most common mutation found in Scandinavian

countries,D90A-SOD1,is more slowly progressive than typical ALS

and patients with this form of the disease survive for an average of

11 years.

Another very common cause of ALS is alesion to the motor system

in areas such as the frontotemporal lobes. Lesions in these areas

often show signs of early deficit, which can be used to predict theloss ofmotor function,and result in the spread of ALS.

Pathophysiology:

The defining feature of ALS is the death of both upper and lower

motor neurons in the motor cortex of the brain, the brain stem, and

the spinal cord. Prior to their destruction, motor neurons develop

protein-richinclusionsin their cell bodies andaxons.This may be

partly due to defects in protein degradation. These inclusions oftencontainubiquitin,and generally incorporate one of the ALS-

associated proteins:SOD1,TAR DNA binding protein (TDP-43, or

TARDBP), orFUS.

9
http://en.wikipedia.org/wiki/Chromosome_21http://en.wikipedia.org/wiki/Superoxide_dismutasehttp://en.wikipedia.org/wiki/Autosomal_dominanthttp://en.wikipedia.org/w/index.php?title=D90A-SOD1&action=edit&redlink=1http://en.wikipedia.org/wiki/Lesionhttp://en.wikipedia.org/wiki/Motor_functionhttp://en.wikipedia.org/wiki/Inclusion_bodieshttp://en.wikipedia.org/wiki/Axonhttp://en.wikipedia.org/wiki/Ubiquitinhttp://en.wikipedia.org/wiki/SOD1http://en.wikipedia.org/wiki/TDP-43http://en.wikipedia.org/wiki/FUShttp://en.wikipedia.org/wiki/FUShttp://en.wikipedia.org/wiki/TDP-43http://en.wikipedia.org/wiki/SOD1http://en.wikipedia.org/wiki/Ubiquitinhttp://en.wikipedia.org/wiki/Axonhttp://en.wikipedia.org/wiki/Inclusion_bodieshttp://en.wikipedia.org/wiki/Motor_functionhttp://en.wikipedia.org/wiki/Lesionhttp://en.wikipedia.org/w/index.php?title=D90A-SOD1&action=edit&redlink=1http://en.wikipedia.org/wiki/Autosomal_dominanthttp://en.wikipedia.org/wiki/Superoxide_dismutasehttp://en.wikipedia.org/wiki/Chromosome_21


11/19

22-08-2014


Diagnosis:

No test can provide a definite diagnosis of ALS, although the

presence of upper and lower motor neuron signs in a single limb is

strongly suggestive. Instead, the diagnosis of ALS is primarilybased on the symptoms and signs thephysicianobserves in the

patient and a series of tests to rule out other diseases. Physicians

obtain the patient's full medical history and usually conduct a

neurologic examination at regular intervals to assess whether

symptoms such as muscle weakness, atrophy of muscles,

hyperreflexia, and spasticity are getting progressively worse.

Certainelectromyography(EMG) findings can support thediagnosis of ALS. Another common test measuresnerve conduction

velocity(NCV).

Management:

Riluzole(Rilutek) is the only treatment that has been found to

improve survival but only to a modest extent. It lengthens survival

by several months, and may have a greater survival benefit for

those with a bulbar onset. It also extends the time before a person

needs ventilation support. Riluzole does not reverse the damage

already done to motor neurons, and people taking it must be

monitored for liver damage (occurring in ~10% of people taking the

drug). It is approved byFood and Drug Administration (FDA) and

recommended by theNational Institute for Clinical

Excellence(NICE).

Ice Bucket Challenge:

TheIce Bucket Challenge, sometimes called the ALS Ice Bucket

Challenge, is an activity involving dumping a bucket of ice water

on one's head or donating to theALS Associationin the United

10
http://en.wikipedia.org/wiki/Physicianhttp://en.wikipedia.org/wiki/Physicianhttp://en.wikipedia.org/wiki/Physicianhttp://en.wikipedia.org/wiki/Electromyographyhttp://en.wikipedia.org/wiki/Nerve_conduction_velocityhttp://en.wikipedia.org/wiki/Nerve_conduction_velocityhttp://en.wikipedia.org/wiki/Riluzolehttp://en.wikipedia.org/wiki/Food_and_Drug_Administrationhttp://en.wikipedia.org/wiki/National_Institute_for_Clinical_Excellencehttp://en.wikipedia.org/wiki/National_Institute_for_Clinical_Excellencehttp://en.wikipedia.org/wiki/ALS_Associationhttp://en.wikipedia.org/wiki/ALS_Associationhttp://en.wikipedia.org/wiki/National_Institute_for_Clinical_Excellencehttp://en.wikipedia.org/wiki/National_Institute_for_Clinical_Excellencehttp://en.wikipedia.org/wiki/Food_and_Drug_Administrationhttp://en.wikipedia.org/wiki/Riluzolehttp://en.wikipedia.org/wiki/Nerve_conduction_velocityhttp://en.wikipedia.org/wiki/Nerve_conduction_velocityhttp://en.wikipedia.org/wiki/Electromyographyhttp://en.wikipedia.org/wiki/Physician


12/19

22-08-2014


States. It went viral throughoutsocial mediaduring theNorthern

Hemispheresummer of 2014.The challenge dares nominated

participants to have a bucket of ice water poured on their head.

One common stipulation gives 24 hours from the time they are

nominated to complete the dare; otherwise, the participant is

asked to donate money to charity.

How Has Stephen Hawking Lived to 70 with ALS?

One thing that is highlighted by this man's course is that this is an

incredibly variable disorder in many ways. On average people live

two to three years after diagnosis. But that means that half thepeople live longer, and there are people who live for a long, long

time.

Life expectancy turns on two things: the motor neurons running

the diaphragmthe breathing muscles. So the common way

people die is of respiratory failure. And the other thing is the

deterioration of swallowing muscles, and that can lead to

malnutrition and dehydration. If you don't have these two things,

you could potentially live for a long timeeven though you're

getting worse. What's happened to him is just astounding. He's

certainly an outlier.

11
http://en.wikipedia.org/wiki/Social_mediahttp://en.wikipedia.org/wiki/Northern_Hemispherehttp://en.wikipedia.org/wiki/Northern_Hemispherehttp://en.wikipedia.org/wiki/Northern_Hemispherehttp://en.wikipedia.org/wiki/Northern_Hemispherehttp://en.wikipedia.org/wiki/Social_media


13/19

22-08-2014


ALS still doesn't have a cure. What have we learned about the

disease recently that might help us find oneor at leastbetter

treatments?

Beginning in 2006 it became clear that like a lot of otherneurodegenerative diseases, ALS was determined by the

accumulation of abnormal proteins in the brain. Ten percent of

ALS is genetic and based on a gene mutation. There are also at-risk

genes for ALS, but there are now multiple genes that have been

identified as potentially causing the disease. Each one of them are

interesting in that they lead to the accumulation of different

proteins in the brain. Knowing specific genes gives us particular

mechanisms in the brain, and would potentially give us targets fortherapies. But none of this has given us any robust therapies yet.

Anurag Chanda

Student (B.Pharm, 4thYear)

DISEASE RELATED BREAKING NEWS

Ebola virus disease, West Africa (20thAugust,

2014)Between 17 and 18 August 2014, a total of 221 new cases of Ebola

virus disease (laboratory-confirmed, probable, and suspect

cases) as well as 106 deaths were reported from Guinea, Liberia,

Nigeria, and Sierra Leone.Read more

UPCOMING EVENTS

5thInternational Conference on Stem Cells and Cancer 2014, JNU

Convention Centre, New Delhi, India from 8-10 November, 2014

12
http://www.scientificamerican.com/article.cfm?id=playing-defense-against-lhttp://www.scientificamerican.com/article.cfm?id=playing-defense-against-lhttp://www.scientificamerican.com/article.cfm?id=playing-defense-against-lhttp://www.who.int/csr/don/2014_08_20_ebola/en/http://www.who.int/csr/don/2014_08_20_ebola/en/http://www.who.int/csr/don/2014_08_20_ebola/en/http://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://d/Jeenat/Bulletin%2034.3_1/New%20Folder/UPCOMING%20EVENTS.docxhttp://www.who.int/csr/don/2014_08_20_ebola/en/http://www.scientificamerican.com/article.cfm?id=playing-defense-against-lhttp://www.scientificamerican.com/article.cfm?id=playing-defense-against-l


14/19

22-08-2014


DRUGS UPDATES

FDA allows marketing of first ZnT8Ab autoantibody

test to help diagnose type 1 diabetes: (20thAugust, 2014)

U.S. Food and Drug Administration allowed marketing of the first

zinc transporter 8 autoantibody (ZnT8Ab) test that can help

determine if a person has type 1 diabetes and not another type of

diabetes. When used with other tests and patient clinical

information, the test may help some people with type 1 diabetesreceive timely diagnosis and treatment for their disease.Read more

CAMPUS NEWS

The Freshers welcome programme was held on 14thAugust, 2014.Welcome 1styear students.

We congratulate the following M.Pharm. final year students who

have made their positions in different pharmaceutical companies.Anirban Banerjee (Emami Ltd.)

Mahender Roy (Stadmed private Ltd.)

We congratulate the following B.Pharm. final year students fortheir success.

Samadrita Mukherjee (Abbott India Ltd.)

Suman Sarkar (Tata Medical Centre-Apollo Pharmacy)

Shrewashee Mukherjee (Fresenius Kabi-Parenteral Nutrition)Avishek Naskar (Glaxo SmithKline-Marketing)

Bappaditya Manik (USV Limited)

Sarbani Das (Nutri Synapzz-Marketing)

Ankita Roy (Nutri Synapzz-Marketing)

13
http://www.drugs.com/news/fda-allows-marketing-first-znt8ab-autoantibody-test-help-diagnose-type-1-diabetes-52841.htmlhttp://www.drugs.com/news/fda-allows-marketing-first-znt8ab-autoantibody-test-help-diagnose-type-1-diabetes-52841.htmlhttp://www.drugs.com/news/fda-allows-marketing-first-znt8ab-autoantibody-test-help-diagnose-type-1-diabetes-52841.html


15/19

22-08-2014


Rahul Mitra (B M Pharmaceuticals-Production)

The following B.Pharm. final year students have qualified, GPAT-2014. We congratulate them all.

Utsha SinhaSatarupa Bhattacharya

Sandipan Sarkar

Purbali Chakraborty

Reminiscence, 2014(GNIPST Reunion) was held in Collegecampus on 2ndFebruary,2014.

1st Annual Sports of GNIPST was held on 3rd February,2014 in

College campus ground.An industrial tour and biodiversity tour was conducted in Sikkim

for B.Pharm and B.Sc. students under the supervision of Mr. Asis

Bala, Ms. Jeentara Begum and Ms. Moumita Chowdhury.

B.Pharm 3rd year won the GNIPST Football Champions trophy,2013. B.Pharm 3rdyear won the final match 1-0 against B.Pharm 2nd

year. Deep Chakrabortywas the only scorer of the final.

STUDENTS SECTION

WHO CAN ANSWER FIRST????

Richard Martin Willstatter first

chemically synthesized which

compound?

In 1981 US dept of defense adopted

which technique for selling good?

14


16/19

22-08-2014


Answer of Previous Issues Questions

A) Fields Medal

B)PETA

Identify the person

Answer of Previous Issues Image

J.C.Field

Send your thoughts/

Quiz/Puzzles/games/write-ups or any other

contributions for Students Section

answ ers of this Section at [email protected]

EDITORS NOTE

It is a great pleasure for me to publish the 4th

issue of 36th

Volume

of GNIPST BULLETIN. All the followers of GNIPST BULLETIN

are able to avail the bulletin through facebook account GNIPST

bulletin I am very much thankful to all the GNIPST members and

readers who are giving their valuable comments, encouragements

and supports. I am also thankful to Dr. Abhijit Sengupta, Director

of GNIPST for his valuable advice and encouragement. Special

thanks to Dr. Prerona Saha, Mr. Debabrata Ghosh Dastidar

and Mr. Soumya Bhattacharya for their kind co-operation and

technical supports. Thank you Mr. Soumya Bhattacharyafor the

15
mailto:[email protected]:[email protected]:[email protected]


17/19

22-08-2014


questionnaires of the student section. An important part of the

improvement of the bulletin is the contribution of the readers. You

are invited to send in your write ups, notes, critiques or any kind of

contribution for the forthcoming special and regular issue.

ARCHIVE

Students of GNIPST organized pre puja celebration programme,Saaranya on 7thOctober, 2013 in college Auditorium.

GNIPST organized a garment distribution programme on 28th

September, 2013 at Dakshineswar Kali Temple and Adyapith,Kolkata. On this remarkable event about hundred people have

received garments. More than hundred students and most of the

faculties participated on that day with lot of enthusiasm.

GNIPST celebrated World Heart Day (29th September) andPharmacists Day (25thSeptember)on 25thand 26thSeptember,

2013 in GNIPST Auditorium. A seminar on Violence againstwoman and female foeticide was held on GNIPST Auditorium on

25th September organized by JABALA Action Research

Organization. On 26thSeptember an intra-college Oral and Poster

presentation competition related to World Pharmacists day and

Heart day was held in GNIPST. Ms. Purbali Chakraborty of

B.Pharm 4th year won the first prize in Oral Presentation. The

winner of Poster presentation was the group of Ms. Utsa Sinha,

Mr. Koushik Saha and Mr. Niladri Banerjee(B.Pharm 4thyear).

A good number of students have participated in both the

competition with their valuable views.

16


18/19

22-08-2014


Teachers daywas celebrated on 5thSeptember, 2013 by the

students of GNIPST in GNIPST Auditorium.

A zalea exotic flower ) , the fresher welcome programme fornewcomers of GNIPST in the session 2013-14 was held on 8th

August in GNIPST Auditorium.

One day seminar cum teachers development programme forschool teachers on the theme of Recent Trends of Life Sciences

in Higher Education organized by GNIPST held on 29th June,

2013 at GNIPST auditorium. The programme was inaugurated by

Prof . Asit Guha, Director of JIS Group, Mr. U.S. Mukherjee, DyDirector of JIS Group and Dr. Abhijit Sengupta, Director cum

Principal of GNIPST with lamp lighting. The programme started

with an opening song performed by the B.Pharm students of this

institute. The seminar consists of a series of lectures, video

presentations and poster session. On the pre lunch session 4

lectures were given by Dr. Lopamudra Dutta, Mr. Debabrata

Ghosh Dastidar, Ms. Swati Nandy and Ms. Tamalika Chakraborty

respectively. On their presentation the speakers enlighten the

recent development of Pharmacy, Genetics and Microbiology and

their correlation with Life Sciences. On the post lunch session,

Ms. Saini Setua and Ms. Sanchari Bhattacharjee explained the

recent development and career opportunities in Biotechnology

and Hospital Management. The programme was concluded with

valedictory session and certificate distribution.

About 50 Higher secondary school teachers from differentschools of Kolkata and North& South 24 Parganas district of

West Bengal participated in this programme. A good interactive

session between participants and speakers was observed in the

seminar. The seminar was a great success with the effort of

17


19/19

22-08-2014


faculties, staffs and students of our Institute. It was a unique

discussion platform for school teachers and professional of the

emerging and newer branches of Life Science.

The general body meeting of APTI, Bengal Branch has beenconducted at GNIPST on 15th June, 2012. The program started

with a nice presentation by Dr. Pulok Kr. Mukherjee, School of

Natural Products, JU on the skill to write a good manuscript for

publication in impact journals. It was followed by nearly two hour

long discussion among more than thirty participants on different

aspects of pharmacy education. Five nonmember participants

applied for membership on that very day.

GNIPST is now approved by AICTE and affiliated to WBUT for

conducting the two years post graduate course (M.Pharm)

in P H A R M A C O L O G Y .The approved number of seat is 18.

The number of seats in B.Pharm. has been increased from 60 to

120.

AICTE has sanctioned a release of grant under Research

Promotion Scheme (RPS) during the financial year 2012-13to

GNIPST as per the details below:

a. Beneficiary Institution:Guru Nanak Institution of Pharmaceutical

Science & Technology.

b.Principal Investigator:Dr. LopamudraDutta.

c. Grant-in-aid sanctioned:Rs. 16,25000/- only

d.Approved duration: 3 years

e. Title of the project: Screening and identification of potential

medicinal plant of Purulia & Bankura districts of West Bengal

with respect to diseases such as diabetes, rheumatism, Jaundice,

hypertension and developing biotechnological tools for enhancing

bioactive molecules in these plants.

GNIPST Bulletin 36.4

Documents

Transcript of GNIPST Bulletin 36.4